Bone biopsy findings in patients receiving long-term bisphosphonate therapy for glucocorticoid-induced osteoporosis.
Masahiko TakahataTomohiro ShimizuSatoshi YamadaTomomaya YamamotoTomoka HasegawaRyo FujitaHideyuki KobayashiTsutomu EndoYoshinao KoikeNorio AmizukaMasahiro TodohJun-Ichiro OkumuraTomomichi KajinoNorimasa IwasakiPublished in: Journal of bone and mineral metabolism (2022)
Our findings indicate that patients receiving long-term BP for GIO are still at high risk for fragility fractures because of poor bone quality.